Effects of carvedilol on cardiomyocyte apoptosis and gene expression in vivo after ischemia-reperfusion in rats

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 23, Issue 2, 2003, Pages 127-130

  Zeng, Hesong ^a   Liu, Xiaochun ^b   Zhao, Huayue ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Apoptosis; Carvediloli; Gene expression; Ischemia reperfusion

Indexed keywords

APOPTOSIS; CARVEDILOLI; GENE EXPRESSION; ISCHEMIA REPURFUSION;

CELLS; DENSITY (OPTICAL); DISEASE CONTROL; GENES; HISTOLOGY; IMAGE PROCESSING; IMMUNOLOGY; MATHEMATICAL MODELS;

CARDIOLOGY;

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BAX PROTEIN, RAT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBAZOLE DERIVATIVE; CARVEDILOL; ONCOPROTEIN; PROPANOLAMINE DERIVATIVE; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL; APOPTOSIS; ARTICLE; DRUG EFFECT; GENE EXPRESSION; GENETICS; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; METABOLISM; PATHOLOGY; RANDOMIZATION; RAT; REPERFUSION INJURY; WISTAR RAT;

ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CARBAZOLES; GENE EXPRESSION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; PROPANOLAMINES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RANDOM ALLOCATION; RATS; RATS, WISTAR;

EID: 3142574657     PISSN: 0257716X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Piper H M, Garcia-Dorado D, Ovize M. A fresh look at reperfusion injury. Cardiovasc Res, 1998, 38(2):291
2. Maxwell S R, Lip G Y. Reperfusion injury: a review of the pathophysiology, clinical manifestations and therapeutic options. Intern J Cardiol, 1997, 58(2):95
3. Fliss H, Gaottinger D. Apoptosis in ischemic and reperfusion rat myocardium. Circ Res, 1996, 79(5):949
4. Palojoki E, Saraste A. Eriksson A et al. Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in rats. Am J Physiol Heart Circ Physiol, 2001, 280, H2726
5. Holleyman C R, Larson D F. Apoptosis in the ischemic reperfused myocardium. Perfusion, 2001, 16(6):491
6. Maulik N, Sasaki H, Galang N. Differential regulation of apoptosis by ischemia-reperfusion and ischemic adapta tion. Ann N Y Acad Sci, 1999, 874:401
7. Freude B, Masters T N, Robicsek F et al. Apoptosis is initiated by myocardial ischemia and executed during reperfusion. J Mol Cell Cardiol, 2000, 32(2):97
8. Feuerstein G Z, Bril A, Ruffolo R R Jr. Protective effects of carvedilol in the myocardium. Am J Cardiol, 1997, 80(11A):41L
9. Gao F, Chen J, Lopez B L et al. Comparison of bisoprolol and carvedilol cardioprotection in a rabbit ischemia and reperfusion model. Eur J Pharmacol, 2000, 406(1): 109
10. Xie Z, Koyama, Suzuki J et al. Coronary reperfusion following ischemia: different expression of bcl-2 and bax proteins and cardiomyocyte apoptosis. Jpn Heart J, 2001, 42(6): 759
11. Book W M. Carvedilol: a nonselective beta blocking agent with antioxidant properties. Congest Heart Fail, 2002, 8(3):173
12. Yue T L, Ma X L, Wang X W et al. Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia-reperfusion-induced cardiomyocyte apoptosis by carvedilol. Circ Res, 1998, 82:166
13. Habon T, Szabados E, Kesmarky G et al. The effect of carvedilol on enhanced ADP-ribosylation and red blood cell membrane damage caused by free radicals. Cardiovasc Res, 2001, 52(1):153
14. Cook S A, Sugden P H, Clerk A. Regulation of Bcl-2 family protein during development and in response to oxidative stress in cardiac myocyte: association with changes in mitochondria membrane potential. Circ Res, 1999, 85(10):940
15. Liu L, Azhar G, Gao W et al. Bcl-2 and Bax expression in adult rat hearts after coronary occlusion: age-associated differences. Am J Physiol, 1998, 275:R315